L'Hermite M, Badawi M M, Michaux-Duchene A, Robyn C
Clin Endocrinol (Oxf). 1979;11(2):173-7. doi: 10.1111/j.1365-2265.1979.tb03063.x.
Six post-menopausal women were submitted, at 1 month interval, to oral oestriol treatment for 14-day periods at daily doses of 2 and 6 mg. Blood samples were collected for LH, FSH and PRL measurements (by RIA) every other day during treatments as well as during a 14-day control period. Through the effect on LH levels was questionable, oestriol resulted in a clear and significant, although moderate, gradual decrease of mean FSH levels. At the doses used, which are effective in thetreatment of menopausal symptoms, but are devoid of any proliferative effect upon the endometrium, oestriol failed to induce any stimulatory effect on basal PRL secretion in these post-menopausal women.
六名绝经后女性每隔1个月接受一次口服雌三醇治疗,疗程为14天,日剂量分别为2毫克和6毫克。在治疗期间以及14天的对照期内,每隔一天采集血样以测量LH、FSH和PRL(采用放射免疫分析法)。尽管雌三醇对LH水平的影响存在疑问,但它导致平均FSH水平出现明显且显著(尽管较为适度)的逐渐下降。在所使用的剂量下,这些剂量对治疗绝经症状有效且对子宫内膜无任何增殖作用,雌三醇未能对这些绝经后女性的基础PRL分泌产生任何刺激作用。